Newborn screenings for pilot study for adrenoleukodystrophy (ALD)
Ended Awarded Last action
- Contract number
- HHSN27500002
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $509,392
Award facts
- Opportunity
-
- NIHNICHDIDD20153 Solicitation number
- Newborn Screening Pilot Studies Award Notice · Posted May 1, 2015
- Contract value 100% obligated
- $509,392.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,658 | |
| Close Out | -$59,998 | |
| Other Administrative Action | $0 | |
| Original award | $572,048 |
About this award
This federal contract award, valued at $509,392.12, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to the Research Triangle Institute (RTI International) to conduct a newborn screening pilot study for adrenoleukodystrophy (ALD). The contract is part of the Newborn Screening Pilot Studies program and utilizes a cost-plus-fixed-fee pricing type. No set-aside was used for this award.
RTI International, an independent non-profit research organization, will serve as the prime contractor. Two subcontractors were identified: the University of North Carolina at Chapel Hill and Duke University, both of which have extensive experience executing federally-funded research projects across various disciplines. The pilot study aims to evaluate the feasibility and effectiveness of newborn screening for ALD, a rare genetic disorder that can lead to progressive brain damage.
Quick answers
Who was awarded contract HHSN27500002?
HHSN27500002 was awarded to Research Triangle Institute by National Institute of Child Health and Human Development (National Institutes of Health) on September 15, 2016.
How much is contract HHSN27500002 worth?
The government has obligated $509,392 on HHSN27500002.
Which agency awarded contract HHSN27500002?
National Institute of Child Health and Human Development (National Institutes of Health) awarded HHSN27500002, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).
Is contract HHSN27500002 an order under another contract?
Yes. HHSN27500002 is a delivery order under HHSN275201500010I, an indefinite delivery contract, on Newborn Screening Pilot Studies.
Was contract HHSN27500002 competed?
The extent of competition for HHSN27500002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award